CA
NZ
UK
AU
IND
US
An executive at Inspire Medical Systems sold shares last week, a move that has drawn attention to the accelerating demand for obstructive sleep apnea treatments. The transaction, disclosed in a regulatory filing, coincides with a broader uptick in investor interest in sleep apnea stocks, …
Intuitive Surgical’s stock retreated this week as investors weighed solid second‑quarter results against a tempered outlook for procedure growth. The robotic‑surgery leader reported a 16% year‑over‑year increase in worldwide procedures, driven by a 15% rise in da Vinci surgeries and a 36% surge in …
Tamari Shahar, Chief Operating Officer and Director of Global-E Online Ltd. (NASDAQ: GLBE), sold 24,999 ordinary shares on July 17, 2026, at an average price of $37.9815 per share, according to a statement of changes in beneficial ownership filed on July 20, 2026. The …
Devyser Diagnostics posted an 80% gross margin for the second quarter of 2026, keeping the figure in line with its internal target even as sales to its largest distributor fell short of expectations. The shortfall rippled through the European healthcare diagnostics arena, where investors …
EnGene Therapeutics is positioning its experimental bladder cancer therapy detalimogene as a potential best-in-class treatment after reporting a 54% complete response rate in its mid-stage LEGEND study. The company, which filed its latest corporate update on July 17, 2026, is targeting a biologics license …
GameStop Corp. has nearly doubled its stake in eBay Inc. to approximately 10 percent and continues its pursuit of the online marketplace despite its initial $56 billion takeover proposal being rejected in May 2026. Ryan Cohen, GameStop's chairman and chief executive, has withdrawn a …
Aditxt (NASDAQ: ADTX) restructured its senior secured financing on July 16, 2026, by cancelling an existing note and issuing two replacement notes of the same combined principal amount. The amendment also admits a new investor, broadening the pool of capital backers while leaving the …
Avantor (NYSE: AVTR) has successfully refinanced €374,208,296.62 of Euro‑denominated term loans, achieving a 50‑basis‑point reduction in its cost of borrowing and extending its debt maturity profile to October 2032. The newly issued Incremental B‑7 Euro Term Loans are priced at EURIBOR plus a spread …
Craneware’s shares fell sharply today as investors reassessed the outlook for revenue cycle management, a segment dealing with tighter payer reimbursements and escalating operational costs. The decline mirrors broader weakness among healthcare technology firms, where billing accuracy and compliance risks have intensified amid regulatory …
HEXPOL’s 10% jump in share price sparked noticeable movement across the polymer and specialty compounds arena, as market participants saw the company’s solid second‑quarter outcomes as an indicator of a rebound in demand and pricing leverage. The uplift extended to fellow chemical and materials …
Please wait processing your request...